Rampart IC, LLC, based in Birmingham, Alabama, has received a Notice of Intent from the U.S. Patent and Trademark Office (USPTO) confirming the patentability of its lead-free enhanced radiation protection devices. This validation of their U.S. Patent No. 11,660,056 reinforces Rampart’s innovative approach to protecting healthcare professionals from occupational radiation exposure. The company's products, which utilize ClearShield Technology™, are proven to significantly reduce scatter radiation and are designed to eliminate the physical burdens associated with traditional lead aprons. Rampart is committed to advancing radiation safety solutions for clinicians and healthcare institutions.
Thu, 06 Aug 2026 14:00:00 GMT | EIN Presswire